Literature DB >> 272085

Transfer factor: a potential agent for immunotherapy of cancer.

C R Meier, A F LoBuglio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 272085     DOI： 10.1007/bf01556190

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  41 in total

1.  Studies smallpox and complications of smallpox vaccination.

Authors:  C H KEMPE
Journal:  Pediatrics       Date:  1960-08       Impact factor: 7.124

2.  PROGRESSIVE VACCINIA WITH NORMAL ANTIBODIES. A CASE POSSIBLY DUE TO DEFICIENT CELLULAR IMMUNITY.

Authors:  C J O'CONNELL; D T KARZON; A L BARRON; M E PLAUT; V M ALI
Journal:  Ann Intern Med       Date:  1964-02       Impact factor: 25.391

3.  Proceedings: Immunotherapy of malignant disease: the use of viable sensitized lymphocytes or transfer factor prepared from sensitized lymphocytes.

Authors:  E T Krementz; P W Mansell; M O Hornung; M S Samuels; C A Sutherland; E N Benes
Journal:  Cancer       Date:  1974-02       Impact factor: 6.860

4.  Immunotherapy of patients with cancer.

Authors:  G V Smith; P A Morse; G D Deraps; S Raju; J D Hardy
Journal:  Surgery       Date:  1973-07       Impact factor: 3.982

5.  Transfer factor therapy in immuno-deficiencies.

Authors:  C Griscelli; J P Revillard; H Betuel; C Herzog; J L Touraine
Journal:  Biomedicine       Date:  1973-05

6.  Transfer factor: isolation of a biologically active component.

Authors:  J A Neidhart; R S Schwartz; P E Hurtubise; S G Murphy; E N Metz; S P Balcerzak; A F LoBuglio
Journal:  Cell Immunol       Date:  1973-11       Impact factor: 4.868

7.  Randomized trial of transfer factor treatment of human warts.

Authors:  D A Stevens; R A Ferrington; T C Merigan; V A Marinkovich
Journal:  Clin Exp Immunol       Date:  1975-09       Impact factor: 4.330

8.  The Wiskott-Aldrich syndrome. Results of transfer factor therapy.

Authors:  L E Spitler; A S Levin; D P Stites; H H Fudenberg; B Pirofsky; C S August; E R Stiehm; W H Hitzig; R A Gatti
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

9.  Immunotherapy of coccidioidomycosis.

Authors:  A Catanzaro; L Spitler; K M Moser
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

10.  In vitro production of a transfer factor specific for transitional-cell carcinoma of the bladder.

Authors:  G Pizza; D Viza; C Boucheix; F Corrado
Journal:  Br J Cancer       Date:  1976-06       Impact factor: 7.640
View more
  1 in total

1.  Clinical and immunological assessment in breast cancer patients receiving anticancer therapy and bovine dialyzable leukocyte extract as an adjuvant.

Authors:  Humberto H Lara; Liliana Ixtepan Turrent; Elsa N Garza-Treviño; Reyes Tamez-Guerra; Cristina Rodriguez-Padilla
Journal:  Exp Ther Med       Date:  2010-05-01       Impact factor: 2.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.